“…Therefore, the amount of time needed to conceive, create, and optimize a new medicine has been reduced due to advancements in silico drug design. For several decades, virtual screening has been used to identify the best lead compounds with a range of structural features for usage with a specific biological target [ 15 ]. Furthermore, computer-aided drug design has been used to identify, validate and explore various biological properties of marine metabolites including anti-inflammatory, anti-infectious, anti-cancer, antiviral, and anti-microbial effects via virtual screening, molecular docking, and dynamics modelling [ 16 , 17 ].…”